C
Celgene Corporation was an American biopharmaceutical company focused on the discovery, development, and commercialization of therapeutics for cancer and immunological diseases. It made corporate venture investments in biotech and healthcare startups, and was acquired by Bristol-Myers Squibb in November 2019 for approximately $74 billion.
42% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-b (45% of deals). Average disclosed round size is $67.5M (across 37 rounds with reported amounts).
Portfolio
38
Fund Size
—
Top Stage
Series B
Last 12 Mo
1
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
40 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| BBiond Biologics | Series B | $17M | Jun 2026 |
 Human Longevity Inc (HLI) | Series B | $39.8M | Aug 2024 |
| RRibon | Series B | $65M | Jul 2021 |
| GGNS Healthcare | Series D | $23M | Jul 2019 |
 Vividion Therapeutics | Series B | $82M | Apr 2019 |
 Oncorus | Series B | $79.5M | Jan 2019 |
 Arrakis | Series B | $75M | Jan 2019 |
| AAntengene Corporation | Series B | $120M | Jan 2019 |
 Oncorus, Inc | Series B | $79.5M | Jan 2019 |
| NNantCell | Unknown | — | Dec 2018 |
| SSutro BioPharma, Inc. | Series E | $85.4M | Jul 2018 |
| NNohla Therapeutics | Series B | $45M | May 2018 |
| CCelularity | Growth | — | Feb 2018 |
 Armo BioSciences | Unknown | $67M | Aug 2017 |
 Evelo Biosciences | Series B | $50M | Jul 2017 |
| AArrakis Therapeutics | Series A | $38M | Jan 2017 |
| RRepare Therapeutics | Series A | $68M | Jan 2017 |
 Arcus Biosciences | Series B | $70M | Sep 2016 |
 Cleave Biosciences | Series B | $37M | Aug 2016 |
| AAgenovir | Series A | $10.6M | May 2016 |
 IDEAYA Biosciences | Series A | $46M | May 2016 |
 Jounce | Ipo | $102M | Jan 2016 |
| AAtara | Series B | $38.5M | Dec 2013 |
| AAgios | Series C | $78M | Jan 2011 |
| EEpizyme | Unknown | $25M | Jan 2009 |
Page 1 of 2
Top Co-Investors
Alexandria Venture Investments9 shared
Amgen Ventures8 shared
The Column Group6 shared
GV5 shared
ARCH Venture Partners5 shared
Nextech Invest Ltd.5 shared
Canaan Partners4 shared
Kleiner Perkins4 shared
Osage University Partners4 shared
Surveyor Capital4 shared
Astellas Venture Management4 shared
Perceptive Advisors4 shared
WuXi AppTec3 shared
Foresite Capital3 shared
DAG Ventures3 shared
Casdin Capital3 shared
Versant Ventures3 shared
MPM Capital3 shared
Deerfield3 shared
Alta Partners3 shared
Last updated: 8 September 2026